Glenn Davies

1.4k total citations
39 papers, 1.1k citations indexed

About

Glenn Davies is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Glenn Davies has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 11 papers in Economics and Econometrics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Glenn Davies's work include Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmaceutical Economics and Policy (9 papers). Glenn Davies is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmaceutical Economics and Policy (9 papers). Glenn Davies collaborates with scholars based in United States, United Kingdom and Canada. Glenn Davies's co-authors include Erik J. Dasbach, Steven M. Teutsch, E. Alemao, Douglas J. Watson, Nicholas Bellamy, J.R. Cook, Donald Yin, A. Lawrence Gould, Kaan Tunceli and Éric Van Ganse and has published in prestigious journals such as New England Journal of Medicine, Diabetes and Clinical Infectious Diseases.

In The Last Decade

Glenn Davies

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Davies United States 17 427 246 208 202 136 39 1.1k
Philip Hopkins United Kingdom 22 531 1.2× 231 0.9× 25 0.1× 372 1.8× 62 0.5× 73 1.9k
Kimberly G. Brodovicz United States 24 314 0.7× 190 0.8× 91 0.4× 504 2.5× 950 7.0× 71 2.0k
Frédéric Collart Belgium 23 435 1.0× 90 0.4× 115 0.6× 272 1.3× 105 0.8× 94 1.9k
Rashad S. Barsoum Egypt 22 196 0.5× 146 0.6× 104 0.5× 303 1.5× 82 0.6× 60 2.1k
Faten Aberra United States 14 490 1.1× 159 0.6× 51 0.2× 963 4.8× 24 0.2× 43 1.8k
Javier de Arteaga Argentina 13 316 0.7× 84 0.3× 132 0.6× 162 0.8× 42 0.3× 51 1.3k
Luke R. Smart United States 20 116 0.3× 178 0.7× 37 0.2× 141 0.7× 80 0.6× 65 968
Guillermina Barril Spain 22 116 0.3× 262 1.1× 40 0.2× 740 3.7× 43 0.3× 89 1.6k
Shahriari Ali Reza Iran 5 211 0.5× 72 0.3× 50 0.2× 162 0.8× 150 1.1× 17 1.6k
Cheng‐Ting Hsiao Taiwan 17 184 0.4× 311 1.3× 19 0.1× 146 0.7× 50 0.4× 72 1.1k

Countries citing papers authored by Glenn Davies

Since Specialization
Citations

This map shows the geographic impact of Glenn Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Davies more than expected).

Fields of papers citing papers by Glenn Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Davies. The network helps show where Glenn Davies may publish in the future.

Co-authorship network of co-authors of Glenn Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Davies. A scholar is included among the top collaborators of Glenn Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Davies. Glenn Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNeill, Ann, Glenn Davies, Eliza Kruger, et al.. (2019). Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis. Diabetes Therapy. 10(2). 473–491. 20 indexed citations
2.
3.
Lorenzi, Maria, Baishali Ambegaonkar, Carl A. Baxter, et al.. (2018). Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Clinical Research in Cardiology. 108(5). 487–509. 21 indexed citations
4.
5.
Laires, P.A., et al.. (2015). Cost–effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal. Journal of Medical Economics. 18(8). 565–572. 13 indexed citations
6.
Bash, Lori D., Jessica Buono, Glenn Davies, et al.. (2012). Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation. Cardiovascular Drugs and Therapy. 26(2). 167–179. 43 indexed citations
7.
Reckless, John, Glenn Davies, Kaan Tunceli, Xiaohan Hu, & Philippe Brudi. (2010). Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study. Value in Health. 13(6). 726–734. 20 indexed citations
8.
Dorais, Marc, Diana Chirovsky, Baishali Ambegaonkar, et al.. (2010). Utilization patterns of extended-release niacin in Canada: Analysis of an administrative claims database. Canadian Journal of Cardiology. 26(7). e229–e235. 12 indexed citations
9.
Gould, A. Lawrence, Glenn Davies, E. Alemao, Donald Yin, & J.R. Cook. (2007). Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clinical Therapeutics. 29(5). 778–794. 117 indexed citations
10.
Lordick, Florian, B. Ehlken, Angela Ihbe‐Heffinger, et al.. (2006). Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. European Journal of Cancer. 43(2). 299–307. 41 indexed citations
11.
Davies, Glenn, Erik J. Dasbach, & Steven M. Teutsch. (2004). The Burden of Appendicitis-Related Hospitalizations in the United States in 1997. Surgical Infections. 5(2). 160–165. 60 indexed citations
12.
Davies, Glenn, Erik J. Dasbach, Nancy C. Santanello, Barbara Knorr, & Donna L. Bratton. (2004). The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma. Clinical Therapeutics. 26(11). 1895–1904. 14 indexed citations
13.
Cook, J.R., E. Alemao, Glenn Davies, et al.. (2004). Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal. PharmacoEconomics. 22(S3). 49–61. 21 indexed citations
14.
Santanello, Nancy C., Carla DeMuro‐Mercon, Glenn Davies, et al.. (2000). Validation of a pediatric asthma caregiver diary. Journal of Allergy and Clinical Immunology. 106(5). 861–866. 39 indexed citations
15.
Dasbach, Erik J., Glenn Davies, & Steven M. Teutsch. (2000). Burden of Aspergillosis‐Related Hospitalizations in the United States. Clinical Infectious Diseases. 31(6). 1524–1528. 125 indexed citations
16.
Hausmann, E., et al.. (2000). Outcome Variables in Periodontal Research: Means and Threshold‐Based Site Changes. Journal of Periodontology. 71(4). 555–561. 16 indexed citations
17.
18.
Machtei, Eli E., E. Hausmann, Sara G. Grossi, et al.. (1998). Radiographic and Clinical Responses to Periodontal Therapy. Journal of Periodontology. 69(5). 590–595. 38 indexed citations
19.
Lawrence, Herenia P., Ronald J. Hunt, James D. Beck, & Glenn Davies. (1996). Five-Year Incidence Rates and Intraoral Distribution of Root Caries among Community-Dwelling Older Adults. Caries Research. 30(3). 169–179. 33 indexed citations
20.
Collier, Ann C., Samuel A. Bozzette, Robert W. Coombs, et al.. (1990). A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus Infection. New England Journal of Medicine. 323(15). 1015–1021. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Hopkins Breakdown of academic impact, for papers by Kimberly G. Brodovicz Breakdown of academic impact, for papers by Frédéric Collart Breakdown of academic impact, for papers by Rashad S. Barsoum Breakdown of academic impact, for papers by Faten Aberra Breakdown of academic impact, for papers by Javier de Arteaga Breakdown of academic impact, for papers by Luke R. Smart Breakdown of academic impact, for papers by Guillermina Barril Breakdown of academic impact, for papers by Shahriari Ali Reza Breakdown of academic impact, for papers by Cheng‐Ting Hsiao
Rankless by CCL
2026